Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Invested Capital (2023 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Return on Invested Capital for 6 consecutive years, with 0.42% as the latest value for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 17.0% year-over-year to 0.42%; the TTM value through Dec 2025 reached 0.42%, down 17.0%, while the annual FY2025 figure was 0.34%, 0.0% changed from the prior year.
  • Return on Invested Capital hit 0.42% in Q4 2025 for Agios Pharmaceuticals, down from 0.4% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 0.25% in Q4 2024 and bottomed at 0.46% in Q4 2023.
  • Average Return on Invested Capital over 3 years is 0.38%, with a median of 0.41% recorded in 2023.
  • Year-over-year, Return on Invested Capital increased 21bps in 2024 and then dropped -17bps in 2025.
  • Agios Pharmaceuticals' Return on Invested Capital stood at 0.46% in 2023, then soared by 45bps to 0.25% in 2024, then plummeted by -67bps to 0.42% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.42%, 0.4%, and 0.25% for Q4 2025, Q3 2025, and Q4 2024 respectively.